These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 7328134)

  • 1. Inhibitory effects of N-methyl-D-aspartate (NMDA) and α
    Hwang S; Yoon B; Jo SH
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3149-3161. PubMed ID: 37166464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.
    Li SX; Han Y; Xu LZ; Yuan K; Zhang RX; Sun CY; Xu DF; Yuan M; Deng JH; Meng SQ; Gao XJ; Wen Q; Liu LJ; Zhu WL; Xue YX; Zhao M; Shi J; Lu L
    Mol Psychiatry; 2018 Mar; 23(3):597-608. PubMed ID: 28439098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP
    Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of cerebral blood flow and glucose utilization by dihydroergocristine in the conscious rat.
    Beck T; Vogg P; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):82-7. PubMed ID: 3148865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perivascular potassium and pH as determinants of local pial arterial diameter in cats. A microapplication study.
    Kuschinsky W; Wahl M; Bosse O; Thurau K
    Circ Res; 1972 Aug; 31(2):240-7. PubMed ID: 5049739
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of histamine on pial arteries: a microapplication study.
    Kuschinsky W; Wahl M
    Adv Neurol; 1978; 20():65-9. PubMed ID: 676924
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental electropharmacologic studies of cerebral ischemia (author's transl)].
    Depoortere H
    Rev Electroencephalogr Neurophysiol Clin; 1981; 10(3):207-14. PubMed ID: 7302319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
    Girard PE; Boucher M
    Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct vascular effects of agents used in the pharmacotherapy of cerebrovascular disease on isolated cerebral vessels.
    Young AR; Bouloy M; Boussard JF; Edvinsson L; MacKenzie ET
    J Cereb Blood Flow Metab; 1981; 1(1):117-28. PubMed ID: 7328134
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral vasodilators (second of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug therapy: cerebral vasodilators (first of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(25):1508-13. PubMed ID: 7029283
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.